Lan-Lan Zhong1,2, Hang T T Phan3, Cong Shen1,2, Karina-Doris Vihta3, Anna E Sheppard3, Xi Huang2,4, Kun-Jiao Zeng1,2, Hong-Yu Li5, Xue-Fei Zhang1,2, Sandip Patil1,2, Derrick W Crook3, A Sarah Walker3, Yong Xing1,2, Jia-Lin Lin1,2, Lian-Qiang Feng1,2, Yohei Doi6, Yong Xia7, Nicole Stoesser3, Guo-Bao Tian1,2. 1. Program in Pathobiology, Fifth Affiliated Hospital, Zhongshan School of Medicine, Sun Yat-Sen University, Guangdong, China. 2. Key Laboratory of Tropical Diseases Control (Sun Yat-sen University), Ministry of Education, Guangzhou, China. 3. Modernising Medical Microbiology, Nuffield Department of Medicine, University of Oxford, United Kingdom. 4. Program of Immunology, Affiliated Guangzhou Women and Children's Medical Center, Zhongshan School of Medicine, Guangzhou, China. 5. Department of Clinical Laboratory, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, Guangzhou, China. 6. University of Pittsburgh Medical Center, Pennsylvania. 7. Department of Clinical Laboratory Medicine, Third Affiliated Hospital of Guangzhou Medical University, Guangdong, China.
Abstract
Background: mcr-1-mediated colistin resistance in Enterobacteriaceae is concerning, as colistin is used in treating multidrug-resistant Enterobacteriaceae infections. We identified trends in human fecal mcr-1-positivity rates and colonization with mcr-1-positive, third-generation cephalosporin-resistant (3GC-R) Enterobacteriaceae in Guangzhou, China, and investigated the genetic contexts of mcr-1 in mcr-1-positive 3GC-R strains. Methods: Fecal samples were collected from in-/out-patients submitting specimens to 3 hospitals (2011-2016). mcr-1 carriage trends were assessed using iterative sequential regression. A subset of mcr-1-positive isolates was sequenced (whole-genome sequencing [WGS], Illumina), and genetic contexts (flanking regions, plasmids) of mcr-1 were characterized. Results: Of 8022 fecal samples collected, 497 (6.2%) were mcr-1 positive, and 182 (2.3%) harbored mcr-1-positive 3GC-R Enterobacteriaceae. We observed marked increases in mcr-1 (0% [April 2011] to 31% [March 2016]) and more recent (since January 2014; 0% [April 2011] to 15% [March 2016]) increases in human colonization with mcr-1-positive 3GC-R Enterobacteriaceae (P < .001). mcr-1-positive 3GC-R isolates were commonly multidrug resistant. WGS of mcr-1-positive 3GC-R isolates (70 Escherichia coli, 3 Klebsiella pneumoniae) demonstrated bacterial strain diversity; mcr-1 in association with common plasmid backbones (IncI, IncHI2/HI2A, IncX4) and sometimes in multiple plasmids; frequent mcr-1 chromosomal integration; and high mobility of the mcr-1-associated insertion sequence ISApl1. Sequence data were consistent with plasmid spread among animal/human reservoirs. Conclusions: The high prevalence of mcr-1 in multidrug-resistant E. coli colonizing humans is a clinical threat; diverse genetic mechanisms (strains/plasmids/insertion sequences) have contributed to the dissemination of mcr-1, and will facilitate its persistence.
Background: mcr-1-mediated colistin resistance in Enterobacteriaceae is concerning, as colistin is used in treating multidrug-resistant Enterobacteriaceae infections. We identified trends in human fecal mcr-1-positivity rates and colonization with mcr-1-positive, third-generation cephalosporin-resistant (3GC-R) Enterobacteriaceae in Guangzhou, China, and investigated the genetic contexts of mcr-1 in mcr-1-positive 3GC-R strains. Methods: Fecal samples were collected from in-/out-patients submitting specimens to 3 hospitals (2011-2016). mcr-1 carriage trends were assessed using iterative sequential regression. A subset of mcr-1-positive isolates was sequenced (whole-genome sequencing [WGS], Illumina), and genetic contexts (flanking regions, plasmids) of mcr-1 were characterized. Results: Of 8022 fecal samples collected, 497 (6.2%) were mcr-1 positive, and 182 (2.3%) harbored mcr-1-positive 3GC-R Enterobacteriaceae. We observed marked increases in mcr-1 (0% [April 2011] to 31% [March 2016]) and more recent (since January 2014; 0% [April 2011] to 15% [March 2016]) increases in human colonization with mcr-1-positive 3GC-R Enterobacteriaceae (P < .001). mcr-1-positive 3GC-R isolates were commonly multidrug resistant. WGS of mcr-1-positive 3GC-R isolates (70 Escherichia coli, 3 Klebsiella pneumoniae) demonstrated bacterial strain diversity; mcr-1 in association with common plasmid backbones (IncI, IncHI2/HI2A, IncX4) and sometimes in multiple plasmids; frequent mcr-1 chromosomal integration; and high mobility of the mcr-1-associated insertion sequence ISApl1. Sequence data were consistent with plasmid spread among animal/human reservoirs. Conclusions: The high prevalence of mcr-1 in multidrug-resistant E. coli colonizing humans is a clinical threat; diverse genetic mechanisms (strains/plasmids/insertion sequences) have contributed to the dissemination of mcr-1, and will facilitate its persistence.
Authors: Michael R Mulvey; Laura F Mataseje; James Robertson; John H E Nash; Patrick Boerlin; Baldwin Toye; Rebecca Irwin; Roberto G Melano Journal: Lancet Infect Dis Date: 2016-03 Impact factor: 25.071
Authors: Erik Snesrud; Susu He; Michael Chandler; John P Dekker; Alison B Hickman; Patrick McGann; Fred Dyda Journal: Antimicrob Agents Chemother Date: 2016-10-21 Impact factor: 5.191
Authors: Aiqing Li; Yong Yang; Minhui Miao; Kalyan D Chavda; José R Mediavilla; Xiaofang Xie; Ping Feng; Yi-Wei Tang; Barry N Kreiswirth; Liang Chen; Hong Du Journal: Antimicrob Agents Chemother Date: 2016-06-20 Impact factor: 5.191
Authors: Alberto Quesada; María Ugarte-Ruiz; M Rocío Iglesias; M Concepción Porrero; Remigio Martínez; Diego Florez-Cuadrado; María J Campos; María García; Segundo Píriz; José Luis Sáez; Lucas Domínguez Journal: Res Vet Sci Date: 2016-02-06 Impact factor: 2.534
Authors: Nenad Macesic; Sabrina Khan; Marla J Giddins; Daniel E Freedberg; Susan Whittier; Daniel A Green; E Yoko Furuya; Elizabeth C Verna; Medini K Annavajhala; Angela Gomez-Simmonds; Anne-Catrin Uhlemann Journal: Antimicrob Agents Chemother Date: 2019-05-24 Impact factor: 5.191
Authors: Jilei Zhang; Li Chen; Jiawei Wang; Patrick Butaye; Ke Huang; Haixiang Qiu; Xiaomei Zhang; Weijuan Gong; Chengming Wang Journal: BMC Res Notes Date: 2018-02-20